BBVA
LPCN icon

Banco Bilbao Vizcaya Argentaria’s Lipocine LPCN Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-11,765
Closed -$252K – 726
2020
Q2 		$252K Buy
+11,765
New +$152K 0.01% 660

Other funds holding LPCN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $80.9B AUM 26.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $9.11B AUM 26.3% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's LPCN Position: Q3 2020 in Review

Banco Bilbao Vizcaya Argentaria sold out of Lipocine (LPCN) in Q3 2020, closing a stake of 11,765 shares — an estimated $252K sold.

Banco Bilbao Vizcaya Argentaria first reported a position in LPCN in Q2 2020 and held it in 1 quarter. The position peaked at $252K in Q2 2020. 29 funds tracked by Wall St. Rank hold LPCN as of Q3 2020.

  • Banco Bilbao Vizcaya Argentaria reported no remaining Lipocine position as of Q3 2020 after selling out during the quarter.
  • Banco Bilbao Vizcaya Argentaria sold 11,765 Lipocine shares in Q3 2020, an estimated $252K.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Lipocine in Q2 2020 and held it in 1 quarter.
  • Banco Bilbao Vizcaya Argentaria's Lipocine position peaked at $252K in Q2 2020.
  • 29 funds tracked by Wall St. Rank held Lipocine as of Q3 2020.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q3 2020, filed 12 Nov 2020.